Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: To determine prognostic indicators for morbidity and mortality in patients with fulminant hepatic failure.

Design: Observational study.

Place And Duration Of Study: Department of Gastroenterology and Hepatology, Shaikh Zayed Postgraduate Medical Institute, Lahore, from April 2003 to June 2005.

Patients And Methods: Forty five patients with confirmed diagnosis of fulminant hepatic failure were included in this study. They were investigated for acute viral serology, complete blood count, liver function tests, renal function tests, serum electrolytes, arterial blood gases, initially daily and then on alternate days. Patients were followed in high dependency/ICU at the Shaikh Zayed Postgraduate Medical Institute. Data were analyzed by logistic regression analysis to identify predictors of mortality and morbidity.

Results: Of the 45 subjects, 31 were males and 14 females. Twenty four patients were positive for acute hepatitis E. Twenty patients recovered fully, whereas 25 died with mortality rate of 55.6 %. Variables i.e. presence of non-A non-B viral hepatitis, serum creatinine > 2.0 mg/dl, serum phosphate > 3.5 mg/dl and sepsis were found to have significant association with mortality on linear correlation. Only serum creatinine more than 2.0 mg/dl, serum phosphate > 3.5 mg/dl and development of sepsis were found to predict the outcome after multivariate analysis.

Conclusion: Patients with serum creatinine > 2.0 mg/dl, serum phosphate > 3.5 mg/dl and sepsis showed adverse prognosis for survival.

Download full-text PDF

Source

Publication Analysis

Top Keywords

fulminant hepatic
12
serum creatinine
12
creatinine mg/dl
12
mg/dl serum
12
serum phosphate
12
phosphate mg/dl
12
hepatic failure
8
shaikh zayed
8
zayed postgraduate
8
postgraduate medical
8

Similar Publications

Case Report: Immune-mediated acute liver failure induced by tislelizumab in a patient with advanced cervical cancer.

Front Oncol

August 2025

Hunan Cancer Hospital, The Affiliated Cancer Hospital, Xiangya School of Medicine, Central South University, Changsha, Hunan, China.

Tislelizumab, an anti-PD-1 monoclonal antibody, is associated with immune-related hepatitis in 1.8% of cases, but reports of acute liver failure (ALF) remain exceedingly rare. We present a case of fulminant hepatitis and ALF following Tislelizumab therapy in a 55-year-old woman with locally advanced cervical adenocarcinoma.

View Article and Find Full Text PDF

Background: Yellow fever virus (YFV) remains a re-emerging zoonotic threat in South America. While epizootics in free-ranging spp. are well-documented, little is known about YFV infection in other Neotropical non-human primates (NHPs), particularly in captive settings.

View Article and Find Full Text PDF

Hepatitis A virus (HAV) typically causes a self-limiting illness in children. Rarely, it can progress to fulminant hepatic failure (FHF), and even less commonly, may be followed by features suggestive of autoimmune hepatitis (AIH). The diagnostic overlap can be particularly challenging in tropical regions, where endemic infections such as dengue and malaria may present with similar clinical features.

View Article and Find Full Text PDF

Drug-induced liver injury (DILI) is a leading cause of acute liver failure in the U.S., though allopurinol and colchicine have not been widely associated with fulminant hepatic failure.

View Article and Find Full Text PDF

Liver Transplantation in Childhood: A 2-Year Single Center Experience.

Transplant Proc

August 2025

Florya VM Medical Park Application and Research Hospital, Organ Transplantation Center, Dr. Istanbul Aydın University, Istanbul, Turkey.

Objective: Liver transplantation is currently the most treatment for fulminant hepatitis, end-stage liver failure, hepatocellular carcinoma, and liver-originated metabolic diseases in children. With technological advances, improvements in surgical techniques and immunosuppressive therapy protocols have increased 1-year survival rates to 80%-90%. Our center successfully performs both living donor and cadaveric liver transplants in children.

View Article and Find Full Text PDF